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HBeAg expression at a transcriptional level. The envelope
genes were characterised in a total of 18 HCC patients, the
pre-S gene was mutated in 72% of the patients. Deletions
across pre-S1/pre-S2, pre-S2 initiation codon mutations with
internal deletions and S gene nonsense mutations were
prevalent. The HBV mutations described in this study have
been associated with increased risk for HCC.
doi:10.1016/j.ijid.2008.05.1241
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Background: Transfusions can be a quick and easy route
for the transmission of infectious agents such as HIV, HBV and
HCV. Evaluation of the prevalence among blood donors (BDs)
is a common and easy method to obtain the epidemiology of
these infections in a community. We performed this study to
determine HIV, HBV and HCV seroprevalence among BDs in
one of the main commercial ports in Iran.
Methods: The sample included 5409 consecutive donors
(17—65 years) who donated blood from 2002 to 2003. HBsAg,
anti-HCV and anti-HIV were investigated by ELISA in blood
samples. If the results of ELISA samples were reported to
be positive in the HIV and HCV cases, the conﬁrmation was
done with RIBA/Western blot
Results: Most of BDs were motivated ones with 42%; who
donate at regular intervals, 38% were ﬁrst-time voluntary
and 20% were voluntary donors with the history of at least
one donation. Among BDs, 95.7% were male. The seropreva-
lence of HBsAg, HCV-Ab and HIV-Ab among BDs was 2.4%,
3.7% and 1.3% respectively in the ﬁrst evaluation while 78.1%
of positive HCV-Ab and 92.3% of positive HIV-Ab were neg-
ative in RIBA (Western blot). The prevalence of HBsAg and
HCV infections among ﬁrst BDs differ from other donors sig-
niﬁcantly. Also married persons were infected with HBV and
HCV more than singles.
Conclusion: HIV and hepatitis transmission through blood
transfusion is a major concern in developing countries such
as Iran where economic constraints limit blood supply safety.
On the other hand, demand for blood transfusion is high
and despite tremendous strides in preventing viral infec-
tion through careful donor screening and viral testing, it is
remain the risk transfusion-transmissible viral diseases.
doi:10.1016/j.ijid.2008.05.1242
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Background: Chronic viral hepatitides, their long-term
consequences, the great number of individuals passed
through infection and socio-economic implications rep-
resent arguments for comprehensive studying of these
diseases. Hepatitis C virus (HCV) infection is endemic all
over the world, its prevalence varying between 0.5% and
5%. HCV genotype and viral load affect treatment response.
HCV genome is conserved among genotypes but the variabil-
ity of the virus variants allows tracing infections by sequence
analysis. In order to evaluate the nosocomial transmission of
HCV infection in a urology clinic, a phylogenetic analysis of
HCV strains was performed in the core genomic region.
Methods: Using COBAS CORE II ELISA technique for
detecting anti-HCV antibodies we tested ten sera prelevated
from a urology clinic. We performed COBAS AMPLICOR HCV
MONITORTM test in the positive sera for the viral load. We
found a signiﬁcant viral load in seven cases, which were
submitted to Neighbor-Joining phylogenetic analysis and
interpreted with MEGA 3 Program. The phylogenetic analy-
sis, based on the HCV core region, was realized by comparing
the ampliﬁed sequences from the four sera with other Roma-
nian sequences from genotype 1b strains and with other
different geographic genotypes’ sequences, selected from
data bases
Results: We found a strong recent epidemiological link for
three genotype 1b strains, which form a group, the genetic
distance between them being very short (0.004—0.007). The
other HCV strains served as controls and manifested differ-
ent lineage degrees between themselves or compared with
other analyzed strains.
Conclusion: This study conﬁrmed the strong relationship
between three HCV strains and the nosocomial transmission
of the infection. Phylogenetic analysis in the core region
represents a useful tool for tracing infections and routes of
viral transmission.
doi:10.1016/j.ijid.2008.05.1243
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Background: Previous studies have shown that both geno-
types 1b and 6a HCV were common among injecting drug
users (IDU) in Hong Kong, but absence of subjects char-
acteristics make further understanding of the molecular
epidemiology difﬁcult. We earlier reported a high preva-
lence of 85% of HCV in local IDUs. The present analysis was
subsequently conducted to characterize the HCV genotypes
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of these anti-HCV positive cases; and to identify any rela-
tionships with injecting behaviours.
Methods: A community-based HCV survey was conducted
in methadone clinics in Hong Kong in 2006. Only injectors
were included. Demographics and drug use pattern were
collected through a questionnaire survey. Blood were col-
lected for anti-HCV tests. RT PCR on NS5B region was then
performed for anti-HCV positive cases.
Results: Serums of 393 anti-HCV positive IDU were avail-
able for genotyping. About 70% (273) were HCV RNA positive;
the rate is higher in male (78%) than female (48%). Alto-
gether the commonest genotype was 6a (143, 52%), followed
by 1b (104, 38%) and 3a (13, 5%). Genotypes 2a, 3b, 6h were
also detected. Genotype 1b became less common among
those started injection more recently and those reported
to have continued sharing injecting equipments in the last
decade. A trend for greater diversity was observed. There
is no discernable difference noted in genotype distribution
regarding injections history in various parts of China and
Hong Kong.
Discussion: Both subtype 1b and 6a have been circulating
among IDU in Hong Kong in the 60s and 70s. In subse-
quent decades genotype 1b has become less dominant while
genotype 3a is getting more common especially among the
younger injectors, an observation similarly reported in China
and elsewhere during growth of IDU epidemic in the 80s.
These sequences will be valuable for evolutionary analy-
sis supporting the identiﬁcation of ancestry of the currently
identiﬁed genotypes.
doi:10.1016/j.ijid.2008.05.1234
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Background: The introduction of pegylated interferon
alfa 2a with ribavirin in therapy of chronic hepatitis C
(CHC) has increased the sustained virological response (SVR)
deﬁned as undetectable HCV RNA sixmonths post treatment.
SVR depends on virus (genotype, viral load) and patient asso-
ciated factors (age, sex, obesities, cirrhosis).
Aim: To evaluate the role of predictive factors: genotype,
viral load and demographic characteristic, age and sex, over
SVR in patients with CHC.
Material and Methods: 75 patients with histological con-
ﬁrmed CHC, positive anti HCV and HCV RNA, were treated at
the Clinic for Infectious Diseases. 53 males and 22 females
from 20 to 66 years of age were divided into two groups:
under vs. above 40 years (55 vs. 20 patients). 41 patients
were with genotype 1 and 33 non-1 genotype (2 genotype 2,
32 genotype 3). Quantitative PCR (Roche Amplicor HCV Test
v 2,0) during the screening protocol quantiﬁed the HCV RNA
level over vs. below 600.000 IU/ml (36 HLV, 39 LVL) Qualita-
tive PCR was performed 6 months after therapy. Patients
received peginterferon alfa-2a (40KD) 180g/weekly and
ribavirin 800/1000/1200mg/d according to genotype.
Results: The overall SVR rate in treated group was 80,0%
(60/75). SVR in patients with genotype 1 was 70,7% (29/41)
and in non-1 genotype 91,2% (31/34) (p = 0,028). SVR in
patients with HVL was 83,3% (30/36) and 84,6% (33/39)
with LVL (p = 0,880). 43/53 (81,1%) male patients and 17/22
(77,3%) female patients had SVR (p = 0,704). In young group
SVR was 89,0% (49/55) and in older than 40 years 55,0%.
(11/20) (p = 0,001).
Conclusion: The efﬁcacy of pegylated interferon alfa 2a
and ribavirin in therapy of CHC was conﬁrmed in our patients
as well. Signiﬁcantly higher SVR rates were obtained in non-1
genotype patients and in younger population group, regard-
less of the sex. Patients infected with genotype 1 and older
patients require individual approach and speciﬁc evaluation
concerning the rapid and early virological response.
doi:10.1016/j.ijid.2008.05.1245
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Aims: To study the quantity and quality of HBV-speciﬁc
T cells in chronic hepatitis B (CHB) patients with different
HBeAg status, and to investigate the extent of liver damage
between HBeAg(+) and HBeAg(−) CHB patients.
Methods: A total of 103 CHB patients were selected and
divided into two groups according to the HBeAg status.
The serum HBV markers, liver damage (necroinﬂamma-
tion gradation) were analyzed. The frequency and Foxp3
expression of CD4+CD25+ regulatory T cells (Treg), the HBV-
pentamer(+) T cell frequency and the expression levels of
PD-1, CTLA-4 on HBV-speciﬁc T cells were measured. HBV
antigens speciﬁc T-cell responses including cellular prolifer-
ation and IFN-  production, with or without anti-PD-1 mAb
and/or anti-CTLA-4 mAb blocking, were also tested in vitro
Results: The demographic characters, serum ALT levels,
the frequency and Foxp3 expression of Treg were sim-
ilar between HBeAg(+) and HBeAg(−) patients, and the
serum HBV DNA levels were higher in HBeAg(+) patients
(P < 0.05). The liver necroinﬂammation was comparatively
severe in HBeAg(−) patients (P = 0.052), while the median
percentage of liver cirrhosis was much higher in HBeAg(+)
patients (P < 0.05). The difference of HBV-speciﬁc T-cell fre-
quency was not signiﬁcant between HBeAg(+) and HBeAg(−)
patients, whereas the expression levels of PD-1 and CTLA-
4 on HBV-pentamer(+) T cells were signiﬁcantly higher
in HBeAg(+) patients (P both < 0.05). Combined using of
anti-PD-1 and anti-CTLA-4 mAb could signiﬁcantly increase
